Andrea Botticelli

Pubblicazioni

Titolo Pubblicato in Anno
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong JOURNAL OF THORACIC DISEASE 2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients JOURNAL OF CLINICAL ONCOLOGY 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting JOURNAL OF CELLULAR PHYSIOLOGY 2017
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis HPB 2017
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients PHARMACOGENOMICS 2017
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort ONCOTARGET 2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy THE EURASIAN JOURNAL OF MEDICINE 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer ANTI-CANCER DRUGS 2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer ONCOTARGET 2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? PLOS ONE 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX ANTI-CANCER DRUGS 2016
F295-fluorouracil degradation rate (5-FU-DR) could predict toxicity in breast cancer patients treated with capecitabine ANNALS OF ONCOLOGY 2016
Genotype–phenotype correlations in 5-fluorouracil metabolism. a candidate DPYD haplotype to improve toxicity prediction PHARMACOGENOMICS JOURNAL 2015
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy WORLD JOURNAL OF ONCOLOGY 2015
Electrochemotherapy treatment of cutaneous metastases from breast cancer THE AMERICAN SURGEON 2015
Positive impact of elastography in breast cancer diagnosis: an institutional experience JOURNAL OF ULTRASOUND 2015
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value? WORLD JOURNAL OF ONCOLOGY 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma